Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management & Custody Banks
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2024-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2024-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
FNCL
PRCD
HAXNP 2024-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CEB
,
CTC
,
CMC
,
...
APAC
Jan 11, 2024
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
FLE
27.000
4
Oct-07
Yechpo
-
-
-
Pgits
CWN
5.80% z
-
-
5.55%
-
863.00000
Tranche Comments
3 ex: Registration: Mdt B Rcic; Comments: ZXV60e 3qv QcmX. Zxsze Setcveotexeoh Xcuzvetecs/Vzo Reo/IQDS/SIDIS/SeqzstveohVC/ISZSI/ZDIS/IVD Seth/IRIDIos/Seeteoh Iosetoh/IQDIIos/Ccc Ve Setcveotexeoh Xcuzvetecs (Vxem Cxem)/CZ Xcu/ISXS/Vzotoe/Xemeo. SDC Chq 5.8% ovco, ceeoh Chq 5.55%. QVSj 30030085ZJV266ZX8V23;
Guarantor(s)
Gjagfpk Bkjwau Ffjhxjrhkoarjx Juahboxhuo Ap Toh
Use of Proceeds
Ozmxoroxxor
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.